Real World Efficacy, Tolerability and Safety of Ubrogepant

被引:0
作者
Chiang, Chia-Chun [1 ]
Arca, Karissa
Dunn, Rachel [3 ]
Girardo, Marlene [2 ]
Quillen, Jaxon [2 ]
Dodick, David
Starling, Amaal
机构
[1] Mayo Clin, Neurol, Rochester, MI USA
[2] Mayo Clin Arizona, Biostat, Phoenix, AZ USA
[3] Mayo Clin Alix Sch Med, Rochester, MI USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
2485
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea
    Lee, Ki Hyun
    Kim, Jinnam
    Lee, Jung Ah
    Kim, Chang Hyup
    Ahn, Jin Young
    Jeong, Su Jin
    Ku, Nam Su
    Choi, Jun Yong
    Yeom, Joon-Sup
    Song, Young Goo
    Kim, Jung Ho
    VIRUSES-BASEL, 2022, 14 (11):
  • [32] EFFICACY AND SAFETY OF UBROGEPANT IN PARTICIPANTS TAKING CONCOMITANT PREVENTIVE MEDICATION
    Blumenfeld, Andrew M.
    Knievel, Kerry
    Adams, Aubrey Manack
    Severt, Lawrence
    Butler, Matthew
    Lai, Hongxin
    Dodick, David W.
    CEPHALALGIA, 2020, 40 : 47 - 48
  • [33] Efficacy and Safety of Ubrogepant in Participants Taking Concomitant Preventive Medication
    Blumenfeld, A. M.
    Knievel, K.
    Adams, Manack A.
    Severt, L.
    Butler, M.
    Lai, H.
    Dodick, D. W.
    HEADACHE, 2020, 60 : 92 - 93
  • [34] Safety and Efficacy of Ubrogepant in Participants With Moderate to High Cardiovascular Risk
    Severt, Lawrence
    Silberstein, Stephen D.
    Blumenfeld, Andrew M.
    Lipton, Richard B.
    Lu, Kaifeng
    Yu, Sung Yun
    Hutchinson, Susan
    NEUROLOGY, 2020, 94 (15)
  • [35] Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments
    van Laar, Sylvia A.
    Kapiteijn, Ellen
    Gombert-Handoko, Kim B.
    Guchelaar, Henk-Jan
    Zwaveling, Juliette
    CANCERS, 2022, 14 (21)
  • [36] Safety, efficacy and tolerability of an ultra-low volume bowel preparation (NER1006) - a real world experience
    Sakiris, Anthony
    Rajandran, Arvinf
    Lynch, Jane
    Rivlin, Myles
    John, Sneha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 266 - 266
  • [37] Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
    Hutchinson, Susan
    Dodick, David W.
    Treppendahl, Christina
    Bennett, Nathan L.
    Yu, Sung Yun
    Guo, Hua
    Trugman, Joel M.
    NEUROLOGY AND THERAPY, 2021, 10 (01) : 235 - 249
  • [38] Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
    Susan Hutchinson
    David W. Dodick
    Christina Treppendahl
    Nathan L. Bennett
    Sung Yun Yu
    Hua Guo
    Joel M. Trugman
    Neurology and Therapy, 2021, 10 : 235 - 249
  • [39] Safety and Efficacy of Blinatumomab- Real World Data
    Apel, Arie
    Ofran, Yishai
    Ram, Ron
    Levi, Itai
    Zektser, Miri
    Koren-Michowitz, Maya
    BLOOD, 2018, 132
  • [40] Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results From a Single-Attack Phase 3 Study, ACHIEVE II
    Trugman, Joel M.
    Dodick, David W.
    Ailani, Jessica
    Lu, Kaifeng
    Lakkis, Hassan
    Finnegan, Michelle
    Szegedi, Armin
    Lipton, Richard B.
    NEUROLOGY, 2019, 92 (15)